Top Markets
#1 Derive Derive +30.11%
#2 Audiera Audiera +18.48%
#3 Cross Cross +16.71%
#4 Cap Cap +10.81%
#5 Humanity Humanity +10.71%
#6 The Bitcoin Bull The Bitcoin Bull +10.16%
#7 Biconomy Biconomy +10.09%
#8 Based Based +8.50%
#9 Velvet Velvet +8.28%
#10 Geodnet Geodnet +8.10%
Coin of the day
Derive Derive
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Dogwood Therapeutics, Inc. Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Rangering i aksjer #35719
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to... Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Aksjekurs
$1.84
Sist synkronisert: 2026-08-11
Markedsverdi
$3.51M
Endring (1 dag)
0.46%
Endring (1 år)
-62.71%
Land
US
Handel Dogwood Therapeutics, Inc. (DWTX)

Kategori

Healthcare
EPS for Dogwood Therapeutics, Inc. (DWTX)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Dogwood Therapeutics, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Dogwood Therapeutics, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE